Kalaris Therapeutics Inc KLRS Q1 2026 Earnings NarrowerthanExpected Loss Highlights Disciplined Spending CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline WTW Q1 2026 Earnings EPS Beats Estimates Amid Modest Market Reaction DNOW Q1 2026 Earnings EPS Misses Estimates by 8775 Shares Decline Coinbase Q1 2026 Earnings Deep Losses on Revenue Miss and Regulatory Overhang BZFD Q1 2026 Earnings WiderThanExpected Loss Sends Shares Higher on Strategic Progress